Back to Screener

Industrials

CryoPort Inc(CYRX)

Live Price

Offline

$15.01

+3.02% today

1Y Change

+110.22%

Window

Jun 25, 2025 โ†’ Jun 18, 2026

Market Cap
$610.00M
Revenue Growth
-24.5%
EPS Growth
+163.3%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 25, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CryoPort Inc (CYRX) is a Industrials stock with a market cap of $610.00M and listed on NASDAQ. The stock last traded around $15.01 and up 110.2% across the available one-year price window (Jun 25, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -24.5%, EPS growth of +163.3%, a dividend yield of 0.0%. What stands out right now is revenue -24.5%, EPS +163.3%, free cash flow +25.5% with operating margin -20.2% and ROIC -6.8%. Valuation is more restrained than many high-expectation growth names at P/E 7.9 and price/sales 3.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CYRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-24.5% vs +6.8% peer median

Operating Margin

Below sector median

-20.2% vs +16.9% peer median

P/E

Below sector median

7.9 vs 36.7 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 6, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -24.5% and EPS is at +163.3%, with operating margin around -20.2%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -2.3% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 6, 2026
โ€”+0.6%+4.4%+27.3%
2026
Mar 3, 2026
-10.5%+2.9%-7.2%-2.5%
2025
Nov 4, 2025
+21.7%-7.5%-4.0%+2.1%

Benchmark Edge

CYRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CYRX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CYRX Max Drawdown

-31.50%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CYRX and SPY.

Calendar-year return history is still loading or unavailable.
CryoPort Inc logo

Company Overview

CryoPort Inc

NASDAQ

Brentwood, TN, United States

Cryoport Inc. is a global provider specializing in temperature-controlled logistics solutions for the life sciences industry. Its primary function is to ensure safe and efficient transportation of temperature-sensitive materials, including biological samples, pharmaceuticals, and other life sciences products. Notable for its comprehensive solutions, Cryoport offers a range of services including cryogenic transportation, monitoring, and logistics management, which are vital for maintaining product integrity and regulatory compliance. The company's offerings significantly impact sectors such as biotechnology, pharmaceuticals, and medical research, where precision and reliability are crucial. Cryoport's logistic services support the entire lifecycle of biopharmaceuticals, from research and development to clinical trials and commercialization. Cryoport's role in the financial market is underscored by its contribution to sustaining critical supply chains in the rapidly growing life sciences sector, making it a cornerstone for companies that rely on precise and secure logistics for their valuable materials. Headquartered in Nashville, Tennessee, Cryoport's innovation and commitment to quality make it a key player in enhancing the global capabilities of temperature-controlled logistic solutions for sensitive biological materials.

Leadership
Mr. Jerrell W. Shelton
Employees
684
Street Address
112 Westwood Place, Suite 350
Mailing
Brentwood, TN, 37027
Region
Brentwood, TN, United States
Last Updated
May 11, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
7.9
EV/EBITDA
โ€”
Price/Sales
3.3
Price/Book
1.2

Growth

Revenue
-24.5%
EPS
+163.3%
Free Cash Flow
+25.5%

Profitability

Gross Margin
47.2%
Operating Margin
-20.2%
Net Margin
42.2%
ROE
16.1%
ROIC
-6.8%

Balance Sheet

Debt/Equity
0.47
Current Ratio
2.09

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 6, 26
โ€”
Est -0.20
โ€”
โ€”
Est 44870.3B
โ€”
โ€”
Mar 3, 26
โœ—
-0.21
Est -0.19
-10.5%
45450.0B
Est 42854.4B
+6.1%
โ€”
Nov 4, 25
โœ“
-0.18
Est -0.23
+21.7%
44233.0B
Est 42923.9B
+3.0%
โ€”
Aug 5, 25
โœ—
-0.29
Est -0.20
-45.0%
45454.0B
Est 41552.0B
+9.4%
โ€”
May 7, 25
โœ“
-0.22
Est -0.23
+4.3%
41040.0B
Est 42422.7B
-3.3%
โ€”
Mar 4, 25
โœ—
-0.42
Est -0.33
-27.3%
59532.0B
Est 58840.2B
+1.2%
โ€”
Nov 7, 24
โœ“
-0.02
Est -0.29
+93.1%
56664.0B
Est 58794.3B
-3.6%
โ€”
Aug 6, 24
โœ“
-0.33
Est -0.37
+10.8%
39709.0B
Est 57680.0B
-31.2%
โ€”
May 7, 24
โœ—
-0.43
Est -0.35
-22.9%
37291.0B
Est 58760.0B
-36.5%
โ€”
Mar 12, 24
โœ—
-0.51
Est -0.32
-59.4%
57260.0B
Est 58400.0B
-1.9%
โ€”
Nov 8, 23
โœ—
-0.31
Est -0.30
-3.3%
56157.0B
Est 55270.0B
+1.6%
โ€”
Aug 9, 23
โœ—
-0.42
Est -0.24
-75.0%
57021.0B
Est 59360.0B
-3.9%
โ€”
May 4, 23
โœ“
-0.16
Est -0.19
+15.8%
62817.0B
Est 62150.0B
+1.1%
โ€”
Feb 23, 23
โœ—
-0.24
Est -0.19
-26.3%
60358.0B
Est 58258.7B
+3.6%
โ€”
Nov 3, 22
โœ—
-0.15
Est -0.14
-7.1%
60464.0B
Est 69949.4B
-13.6%
โ€”
Aug 4, 22
โœ—
-0.17
Est -0.15
-13.3%
64153.0B
Est 64583.0B
-0.7%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.